0.00Open3.74Pre Close0 Volume120 Open Interest75.00Strike Price0.00Turnover122.42%IV2.16%PremiumDec 13, 2024Expiry Date2.08Intrinsic Value100Multiplier0DDays to Expiry1.67Extrinsic Value100Contract SizeAmericanOptions Type0.8546Delta0.1027Gamma32.80Leverage Ratio-1.2631Theta0.0004Rho28.03Eff Leverage0.0041Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet